Contact dermatitis due to personal protective equipment use and hygiene practices during the COVID-19 pandemic: A systematic review of case reports.

COVID-19 Contact dermatitis Dermatology Hygiene Personal protective equipment

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 20 12 2021
revised: 31 12 2021
accepted: 06 01 2022
pubmed: 19 1 2022
medline: 19 1 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

Prolonged use of personal protective equipment (PPE) may lead to contact dermatitis during the coronavirus disease 19 (COVID-19) pandemic. This paper aims to identify the causative factors of contact dermatitis from PPE and hygiene practices. The search was conducted adhering to PRISMA 2020 guidelines. A Delphi process was employed to ensure that the aims of this study were met. PubMed and Web of Science databases were systematically searched through September 12, 2021, using search terms: Contact dermatitis, case report, covid-19. The findings were tabulated as author/year, gender, age, presentation, cause, dermatological diagnosis, testing modality, provided treatment, symptom resolution (time in days), prognosis, and follow-up. The mean age of all individuals was 29.75 years, with 75% females. All cases presented with erythema, with 62.5% reporting pruritus and 37.5% reporting burning facial symptoms. Surgical masks and hand-hygiene products (37.5%) were the most commonly reported causative agent with 25% due to KN95/FFP type 2 use. Allergic contact dermatitis (50%) and irritant contact dermatitis (25%) were common diagnoses. Treatments included creams, emollients, and desloratadine, with restriction of irritant-causing factors. The prognosis was generally good among the cases, with 62.5% presenting complete resolution within a week and 12.5% showing moderate improvement at the fourth month after discontinuing use. This study finds pertinent links between PPE use and contact dermatitis during the COVID-19 pandemic. While many cases are bound to go underreported in literature, well-designed, large-scale studies in the future may help promote these associations in a more comprehensive manner.

Sections du résumé

BACKGROUND BACKGROUND
Prolonged use of personal protective equipment (PPE) may lead to contact dermatitis during the coronavirus disease 19 (COVID-19) pandemic. This paper aims to identify the causative factors of contact dermatitis from PPE and hygiene practices.
METHODS METHODS
The search was conducted adhering to PRISMA 2020 guidelines. A Delphi process was employed to ensure that the aims of this study were met. PubMed and Web of Science databases were systematically searched through September 12, 2021, using search terms: Contact dermatitis, case report, covid-19. The findings were tabulated as author/year, gender, age, presentation, cause, dermatological diagnosis, testing modality, provided treatment, symptom resolution (time in days), prognosis, and follow-up.
RESULTS RESULTS
The mean age of all individuals was 29.75 years, with 75% females. All cases presented with erythema, with 62.5% reporting pruritus and 37.5% reporting burning facial symptoms. Surgical masks and hand-hygiene products (37.5%) were the most commonly reported causative agent with 25% due to KN95/FFP type 2 use. Allergic contact dermatitis (50%) and irritant contact dermatitis (25%) were common diagnoses. Treatments included creams, emollients, and desloratadine, with restriction of irritant-causing factors. The prognosis was generally good among the cases, with 62.5% presenting complete resolution within a week and 12.5% showing moderate improvement at the fourth month after discontinuing use.
CONCLUSION CONCLUSIONS
This study finds pertinent links between PPE use and contact dermatitis during the COVID-19 pandemic. While many cases are bound to go underreported in literature, well-designed, large-scale studies in the future may help promote these associations in a more comprehensive manner.

Identifiants

pubmed: 35039780
doi: 10.1016/j.amsu.2022.103254
pii: S2049-0801(22)00014-0
pmc: PMC8755461
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

103254

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Zouina Sarfraz (Z)

Fatima Jinnah Medical University, Lahore, Pakistan.

Azza Sarfraz (A)

The Aga Khan University, Karachi, Pakistan.

Muzna Sarfraz (M)

King Edward Medical University, Lahore, Pakistan.

Miguel Felix (M)

Universidad Espíritu Santo, Samborondón, Ecuador.
Respiralab, Respiralab Research Group, Guayaquil, Ecuador.

Jonathan A Bernstein (JA)

Department of Internal Medicine, University of Cincinnati College of Medicine, Ohio, USA.

Luz Fonacier (L)

Department of Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA.
Department of Allergy, New York University Winthrop Hospital, Mineola, NY, USA.

Ivan Cherrez-Ojeda (I)

Universidad Espíritu Santo, Samborondón, Ecuador.
Respiralab, Respiralab Research Group, Guayaquil, Ecuador.

Classifications MeSH